2nd Quarter - Termination

HEALTHFUTURES, LLC for LIFE TECHNOLOGIES

Period 2nd Quarter 2011 Filed Jul 12, 2011 Signed by Joyce Briscoe, VP-Administration

Official filing
Firm
HEALTHFUTURES, LLC
Client
LIFE TECHNOLOGIES
Income
$20,000
Expenses
—
Terminated
May 31, 2011

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

No Bill#, Genomics and Personalized Medicine Act, Personalized medicine Health information technology Regulation and reimbursement of laboratory-developed tests No Bill#, BETTER Patient Care Act Whole genome sequencing

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —
KATHRYN SCHUBERT —

Contacted: SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Health Issues HCR

No Bill#, Genomics and Personalized Medicine Act, Personalized medicine Health information technology Regulation and reimbursement of laboratory developed tests Regulatory science No Bill#, BETTER Patient Care Act Whole genome sequencing

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —
KATHRYN SCHUBERT —

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.